Previous Meetings

GBCC 2018

Global Breast Cancer Conference 2018

08:00-08:45
Satellite Symposium 2
Venue: F
  • Management of Febrile Neutropenia by Pegfilgrastim in the United States: Importance of Relative Dose Intensity and Control of Toxic Effects of Chemotherapy in Early Breast Cancer
    Naoto Ueno (The Univ. of Texas MD Anderson Cancer Center, U.S.A.)
09:00-10:00
Plenary Lecture 3
Venue: A
  • The Role of Breast Surgery: Coping with the Present and the Future
    Stephen Grobmyer (Cleveland Clinic, U.S.A.)
10:15-11:45
Symposium 4
Balancing Cosmetic Results and Oncologic Outcomes
Venue: A
  • Individualized Application of Oncoplastic Techniques
    Ho Yong Park (Kyungpook National Univ. Chilgok Hospital, Korea)
  • Evaluation of Cosmetic Outcome and Its Practical Relevance to Real Life
    Eisuke Fukuma (Kameda Medical Center, Japan)
  • How to Standardize Techniques of Oncoplastic Surgery
    Maria-Joao Cardoso (Champalimaud Foundation, Portugal)
Panel Discussion 4
How Can We Better Treat Patients with Metastatic Disease?
Venue: B
  • Role of Primary Resection for Patients with Oligometastatic Disease
    Tadahiko Shien (Okayama Univ. Hospital, Japan)
  • Multimodal Approach to Deal with Bone Metastasis
    Yee Soo Chae (Kyungpook National Univ. Medical Center, Korea)
  • Recent Advances to Treat Tumor Recurrence in CNS
    Hamdy Abdel Azim (Cairo Univ., Egypt)
Education Session 4
Application of AJCC 8th Staging in Practice
Venue: C
  • Overview of AJCC 8th Staging in Pathologic Aspects
    Jeeyeon Kim (Pusan National Univ. Yangsan Hospital, Korea)
  • LCIS: Current Concept and Challenging Issues
    Hironobu Sasano (Tohoku Univ. School of Medicine, Japan)
  • Clinical Implications of Revised AJCC 8th Staging
    Tae Hyun Kim (Inje Univ. Busan Paik Hospital, Korea)
10:45-11:45
Nursing Session 1
Special Session for Breast Cancer Nursing (Korean)
Venue: D
  • Current Trends of Breast Cancer Surgery
    Jong Han Yu (Samsung Medical Center, Korea)
  • Role of Genetic Counseling Nurse in Breast Cancer
    Sung-Won Kim (Daerim St. Mary's Hospital, Korea)
12:00-12:45
Satellite Symposium 3
Venue: A
  • Current and Future Perspectives in Treatment of HER2+ Breast Cancer
    Jee Hyun Kim (Seoul National Univ. Bundang Hospital, Korea)
13:15-14:15
Plenary Lecture 4
Venue: A
  • Marker-guided Targeted Therapy, PARP Inhibitors and Immune Checkpoint Therapy
    Mien-Chie Hung (The Univ. of Texas MD Anderson Cancer Center, U.S.A.)
14:30-16:00
Symposium 5
Issues for Young Women with Breast Cancer
Venue: A
  • Multi-omics Profiling of Younger Asian Breast Cancers Reveals Distinctive Molecular Signatures
    Zhengyan Kan (Pfizer, Inc., U.S.A.)
  • Biology of Breast Cancer in Young Women and Potential Clinical Implications
    Matteo Lambertini (Institut Jules Bordet, Belgium)
  • Fertility Preservation and Pregnancy Options for Young Breast Cancer Survivors
    Olivia Pagani (Oncology Institute of Southern Switzerland (IOSI), Switzerland)
ABRCA & HBOC
Venue: B
  • Breast and Ovarian Cancer Risk Assessment Using Multigene Panel Tests
    Antonis Antoniou (Univ. of Cambridge, United Kingdom)
  • Risk Reduction Strategy for Patients with Genetic Susceptibility to Breast Cancer
    Ava Kwong (Queen Mary Hospital, Univ. of Hong Kong, Hong Kong)
  • Risk Reduction for Ovarian Cancer in Women with BRCA1/2 Mutation
    Min Chul Choi (CHA Bundang Medical Center, CHA Univ., Korea)
Education Session 5
Management Options for Not So Benign Lesions
Venue: C
  • Recent Biology and Treatments for Phyllodes Tumors
    Kong Wee Ong (Singhealth Duke-NUS Breast Centre, Singapore)
  • Treatment Options for the Precancerous Atypical Breast Lesions
    Young-Jin Suh (The Catholic Univ. of Korea, St. Vincent's Hospital, Korea)
  • Management of Atypical Cells on the Margin after Breast Conserving Surgery
    Eun Sook Lee (National Cancer Center, Korea)
Oral Presentation 2
Venue: D
  • EFFICACY AND SAFETY OF ACUPUNCTURE FOR THE HOT FLASHES IN BREAST CANCER PATIENTS TAKING ADJUVANT TAMOXIFEN: A MULTICENTER STUDY IN KOREAN WOMEN
    Hye Ryeon Choi (Catholic Univ. of Daegu School of Medicine, Korea)
  • CANASSIST-BREAST: A COST-EFFECTIVE MORPHOMETRIC IMMUNOHISTOCHEMISTRY TEST FOR PROGNOSTIC RISK STRATIFICATION OF EARLY STAGE ESTROGEN RECEPTOR POSITIVE BREAST CANCER PATIENTS
    Manjiri Bakre (Oncostem Diagnostics, India)
  • FEASIBILITY OF PREOPERATIVE AXILLARY LYMPH NODE MARKING WITH A CLIP IN BREAST CANCER PATIENTS BEFORE NEOADJUVANT CHEMOTHERAPY: A PRELIMINARY STUDY
    Eun Young Kim (Kangbuk Samsung Hospital, Korea)
  • EVOLVING INDICATIONS AND LONG TERM ONCOLOGIC OUTCOMES OF RISK REDUCING BILATERAL NIPPLE SPARING MASTECTOMY
    Stephen Grobmyer (Cleveland Clinic, U.S.A.)
  • ADDED VALUE OF DOPPLER US AND ELASTOGRAPHY PRIOR TO PERCUTANEOUS BIOPSY TO IDENTIFY CANDIDATES FOR AVOIDANCE OF SURGERY IN BREAST CANCER PATIENTS FOLLOWING NEOADJUVANT SYSTEMIC THERAPY
    Soo-Yeon Kim (Seoul National Univ. Hospital, Korea)
  • A PILOT STUDY OF SENTIMAG/SIENNA XP AND THE STANDARD MODALITY FOR SENTINEL LYMPH NODE IDENTIFICATION IN PATIENTS WITH BREAST CANCER
    Julie Liana Hamzah (Singapore General Hospital, Singapore)
  • EXPERIENCE OF USING HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION (HIFU)
    Zhazira Seidagaliyeva (Astana Medical Univ., Kazakhstan)
  • PREDICTION OF PATHOLOGIC COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY
    Han-Byoel Lee (Seoul National Univ. Hospital, Korea)
16:00-18:00
ABCN Business Meeting
Venue: E
  • Where Are We? - Background, Goals, Theme, Subject and Platform
    Sung-Bae Kim (ASAN Medical Center, Korea)
  • Wisdom Sharing: Journey from Africa to International Chairperson: Mentorship and International Collaboration
    Fatima Cardoso (Champalimaud Clinical Centre, Portugal)
  • Challenges and Opportunities of Investigator Initiated Clinical Trials in Asia
    Seock-Ah Im (Seoul National Univ. Hospital, Korea)
  • The Clinical Trial Collaboration in China
    Yongsheng Wang (Shandong Cancer Hospital & Institute, China)
  • Breast Management in Indonesia
    Dimyati Achmad (Hasan Sadikin General Hospital, Indonesia)
  • Facts on Breast Cancer Issues: Philippines
    Victor Gozali (Philippine Breast Cancer Society, Philippines)
  • East Asian Groups & BIG Collaboration
    Shinji Ohno (The Cancer Institute Hospital of JFCR, Japan)
16:15-17:45
Symposium 6
Various Options for Radiotherapy for Optimal Breast Cancer Care
Venue: A
  • Intraoperative Radiation
    Jayant S Vaidya (Univ. College London, United Kingdom)
  • Extended Radiation Field for Advanced Breast Cancer Patients: When and How?
    Jiayi Chen (Ruijin Hospital, Shanghai Jiaotong Univ. School of Medicine, China)
  • Whole Breast Radiation: Classic vs. Hypofractionation
    Kyung Hwan Shin (Seoul National Univ. Hospital, Korea)
Panel Discussion 5
Immune Checkpoint Inhibitors for Breast Cancer
Venue: B
  • Overview of Immune Checkpoint Inhibitors for Breast Cancer Treatment: Beyond PD-1 Blockade
    Sang Jun Ha (Yonsei Univ., Korea)
  • Emerging Tissue or Serum Markers for Immune Checkpoint Inhibitors
    Kyong Hwa Park (Korea Univ. Anam Hospital, Korea)
  • Strategies for the Combination of Immune Checkpoint Inhibitors
    Kyong Hwa Park (On behalf of Prof. Giuseppe Curigliano) (Korea Univ. Anam Hospital, Korea)
Survivorship Session 2
Non-hereditary Risk Factors for Breast Cancer
Venue: C
  • Mammographic Density and Breast Cancer: A Smart Approach to Breast Cancer Control
    John Hopper (Univ. of Melbourne, Australia)
  • Family History and Breast Cancer
    Min-Woo Jo (Univ. of Ulsan College of Medicine, Korea)
  • Nutrition and Diet before and after Breast Cancer
    Jung Eun Lee (Seoul National Univ., Korea)
Nursing Session 2
Supportive Care for Breast Cancer Patients (Korean)
Venue: D
  • Suffering in Patients with Metastatic Breast Cancer
    Jayoung Ahn (ASAN Medical Center, Korea)
  • Necessity of Breast Cancer Yoga Exercise and Method of Its Practice
    Heesun Oh (Research Institute of Nursing Science, Seoul National Univ., Korea)
  • Phenomenological Approach to Breast Cancer
    Woo Joung Joung (Kyungpook National Univ., Korea)
  • Multidisciplinary Approach to Young Breast Cancer Nursing
    Eun Ju Lee (Soonchunhyang Univ. Hospital Cheonan, Korea)
18:00-18:45
Satellite Symposium 4
Venue: F
  • Optimal Treatment Strategy for ER-positive, HER2-negative MBC - Implications from the Clinical Trial and Experience
    Hiroji Iwata (Aichi Cancer Center Hospital, Japan)
Back to Previous Meetings